slides · global inventory
Solution
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 8,880
Current window 4,531-4,560
Pages 296
Rows per page 30
Slide type
4,531-4,560 of 8,880
45
The slide uses a process flow framework to visualize the company's proprietary platform.Absci | IPO Presentation Deck | 65 slides · Absci
Pitch deck Investment bank 1 hit
46
The slide uses a circular process flow with an AI feedback loop at the bottom.Absci | IPO Presentation Deck | 65 slides · Absci
Pitch deck Investment bank 1 hit
47
The slide uses a circular process flow with an AI core, highlighting specific parameters for drug and cell line design.Absci | IPO Presentation Deck | 65 slides · Absci
Pitch deck Investment bank 1 hit
48
The central image is a visualization of a complex molecular structure, likely representing the protein sequence space.Absci | IPO Presentation Deck | 65 slides · Absci
Pitch deck Investment bank 1 hit
50
The slide uses a circular flow diagram connecting 'Predict' and 'Learn' phases via an AI engine, culminating in drug creation.Absci | IPO Presentation Deck | 65 slides · Absci
Pitch deck Investment bank 1 hit
55
The slide uses an icon grid to represent different biological drug formats.Absci | IPO Presentation Deck | 65 slides · Absci
Pitch deck Investment bank 1 hit
64
The slide uses a funnel-like process flow to show the reduction of variants from billions to tens.Absci | IPO Presentation Deck | 65 slides · Absci
Pitch deck Investment bank 1 hit
65
The slide uses a process flow diagram to show the transition from input sequences to functional embedding, homology search, and experimental validation.Absci | IPO Presentation Deck | 65 slides · Absci
Pitch deck Investment bank 1 hit
23
The slide uses a combination of a three-column service breakdown and a comparison table for client case studies.Allego | SPAC Presentation Deck | 37 slides · Allego
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
09
The slide uses a diamond-shaped logo/diagram as a central visual anchor for both the care platform and the growth model.Cano Health | Investor Presentation Deck | 45 slides · Cano Health
Pitch deck Investor relations Beat · Problem1 hit
33
The slide uses a list of four key value propositions alongside a stack of dashboard screenshots.Cano Health | Investor Presentation Deck | 45 slides · Cano Health
Pitch deck Investor relations 1 hit
07
The slide uses a structured grid layout to categorize the company's technology platform and pipeline.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
10
The chart uses a conceptual line graph to show the impact of two specific genetic modifications on the duration of CAR-T cell activity.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
12
The slide serves as a section divider or introduction to the technology stack.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
14
The slide uses a process flow diagram to show the transition from raw materials to patient treatment.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
16
Caribou Biosciences | IPO Presentation Deck | 44 slidesCaribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · TractionLoop · Zoom In1 hit
17
The chart is a flow cytometry plot showing insertion efficiency across two inserts.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · TractionLoop · Zoom In1 hit
18
The slide uses a before/after diagram to explain the biological problem of translocation and a comparative box to show the performance improvement.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · TractionLoop · Zoom In1 hit
21
Uses a before-after comparison framework to explain the mechanism of action.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · Traction1 hit
25
The slide details the transition from healthy donor leukapheresis through genetic modification (using AAV, Cas9, and chRDNA) to final cryopreservation and treatment.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · Traction1 hit
26
Caribou Biosciences | IPO Presentation Deck | 44 slidesCaribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · Traction1 hit
29
The slide uses a biological process diagram to illustrate the 'cloaking' mechanism.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · Traction1 hit
30
The chart shows in vitro cytotoxicity measured 24 hours after co-incubation at various effector-to-target ratios.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · Traction1 hit
36
Caribou Biosciences | IPO Presentation Deck | 44 slidesCaribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · Traction1 hit
38
The diagram shows a multi-step biological process: Gene editing, two stages of differentiation, and expansion.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank 1 hit
40
Caribou Biosciences | IPO Presentation Deck | 44 slidesCaribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank 1 hit
09
The slide uses a biological signaling pathway map as a framework to explain the company's therapeutic strategy.Erasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank Beat · Solution1 hit
11
The slide uses a biological process diagram to map drug candidates to specific protein targets.Erasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank Beat · Solution1 hit
13
The slide uses a biological pathway diagram to illustrate the position of ERK relative to other nodes like MEK and RAF.Erasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank 1 hit
18
The slide uses a comparative experimental design to demonstrate the superior efficacy of ERAS-007 in a specific biological pathway.Erasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank 1 hit